Skip to main content
. 2021 Aug 31;12:662856. doi: 10.3389/fneur.2021.662856

Table 2.

Efficacy endpoints of interest.

Category Endpoint
Disease severity score Quantitative Myasthenia Gravis Scale (QMGS)
Myasthenia Gravis Composite (MGC) Scale
Myasthenia Gravis-Activities of Daily Living (MG-ADL)
Myasthenia Gravis Foundation of America (MGFA) Score
MGFA- Post Intervention Status (MGFA-PIS)
Myasthenia Gravis Disease Scale (MGDS)
Myasthenic Muscle Score (MMS)
Myasthenia Gravis Severity Scale (MSS)
Osserman classification
Other/unspecified scale
Quality of Life (QOL) Short Form 36 (SF-36)
QOL-60
QOL-15
Other QOL scales
Speed of recovery Ventilation time
Hospitalization time
Serological factors AChR antibody titer
MuSK antibody titer
Other Re-hospitalization rate
Recurrent crisis rate
Prednisone dose
Electromyogram (EMG)
Repetitive nerve stimulation